strong
associ
infantil
wheez
respiratori
tract
infect
caus
respiratori
syncyti
viru
rsv
well
establish
studi
older
children
rhinoviru
becom
major
viru
associ
asthma
relationship
outlin
box
page
past
relationship
difficult
appreci
rhinoviru
alway
grow
well
cultur
addit
linkag
asthma
atopi
childhood
rais
question
whether
viral
infect
alon
precipit
exacerb
asthma
use
polymeras
chain
reaction
pcr
measur
viral
nucleic
acid
materi
provid
opportun
studi
virusinduc
wheez
among
children
greater
detail
investig
experiment
rhinoviru
infect
adult
demonstr
viru
augment
earli
late
phase
manifest
airway
hyperreact
articl
review
recent
advanc
enhanc
understand
virusinduc
wheez
along
new
inform
indic
interact
viral
infect
allerg
inflamm
may
critic
pathogenesi
acut
symptom
earli
childhood
wheez
year
life
predispos
risk
factor
prematur
lower
lung
function
birth
matern
smoke
follow
pregnanc
frequent
exposur
viral
infect
day
care
major
risk
factor
acut
attack
viral
infect
especi
rsv
tobacco
smoke
exposur
predispos
risk
factor
genet
predisposit
matern
asthma
atopi
stronger
influenc
asthma
atopi
father
atop
dermat
andor
food
hypersensit
increas
exposur
aeroallergen
earli
life
major
risk
factor
acut
attack
viral
infect
especi
rhinoviru
exposur
aeroallergen
dust
pollen
weed
mold
allergen
tobacco
smoke
exposur
interact
rhinoviru
infect
allerg
inflamm
becom
significantli
associ
wheez
age
year
b
develop
asthma
datafrom
inform
literatur
cite
refer
vast
major
children
becom
infect
rsv
first
year
life
approxim
children
serolog
respons
viru
age
z
keep
rsv
common
viral
respiratori
tract
pathogen
isol
infant
wheez
mani
attack
lead
emerg
room
visit
hospit
occur
within
first
month
life
infant
like
experi
initi
infect
current
inform
indic
rsv
infect
infanc
respons
develop
becom
clear
exampl
infant
wheez
approxim
becom
symptomfre
grow
older
nevertheless
one
third
children
wheez
rsv
risk
recurr
persist
wheez
consider
interest
research
improv
abil
identifi
children
earli
life
becom
appar
exampl
infant
whose
parent
allerg
symptom
asthma
especi
mother
greater
risk
develop
asthma
predispos
event
may
influenc
process
may
even
begin
uterozu
infant
atop
dermat
becom
sensit
food
allergen
earli
life
also
increas
risk
develop
allerg
respiratori
tract
symptom
includ
asthma
grow
l
e
r
among
infant
die
seriou
rsv
diseas
vigor
perivascular
lymphocyt
respons
observ
lung
howev
differ
pathogen
process
also
observ
clinic
trial
formalininactiv
rsv
vaccin
process
led
seriou
pulmonari
diseas
well
peripher
blood
eosinophilia
half
vaccin
recipi
acquir
subsequ
rsv
infect
pulmonari
eosinophilia
characterist
lung
inflamm
asthma
also
note
autopsi
specimen
recipi
mechan
develop
eosinophil
respons
infant
clear
previou
studi
ige
mechan
wheez
propos
infant
base
detect
ige
antibodi
specif
rsv
antigen
nasopharyng
secret
increas
level
histamin
secret
patient
also
report
addit
elev
nasal
eosinophil
cation
protein
ecp
observ
investig
separ
studi
rsv
infect
infant
present
howev
clear
ige
rsv
posit
predict
valu
develop
asthma
high
level
nasal
ecp
ige
rsv
yet
measur
patient
thu
function
ige
rsv
pathogenesi
infantil
wheez
relev
develop
asthma
uncertain
certain
circumst
evid
rsv
infect
may
capabl
induc
th
lymphocyt
respons
lead
develop
eosinophil
inflamm
mice
th
respons
capsular
rsvattach
antigen
g
protein
demonstr
lead
product
lymphocyt
sensit
mice
stimul
vitro
rsvg
mice
also
develop
pulmonari
eosinophilia
follow
subsequ
intranas
infect
quantiti
ige
antibodi
produc
anim
signific
eosinophil
respons
lung
also
produc
bcelldefici
mice
suggest
mechan
independ
ige
antibodi
eosinophil
process
howev
requir
prior
immun
sensit
may
explain
pathogenesi
rsvinduc
wheez
human
experi
initi
infect
earli
infanc
studi
examin
elabor
cytokin
le
may
import
pathogenesi
airway
inflamm
caus
rsv
well
parainfluenza
taken
togeth
understand
infantil
wheez
induc
rsv
increas
substanti
howev
research
lead
new
treatment
vaccin
pharmacolog
agent
counter
advers
effect
rsv
identif
wheez
infant
predispos
develop
asthma
remain
import
problem
studi
schoolag
children
asthma
common
cold
virus
associ
wheez
exacerb
communitybas
studi
asthmat
children
age
use
pcr
analysi
rhinoviru
account
two
third
virus
isol
inspect
symptom
score
chart
reveal
sudden
fall
peak
flow
valu
within
day
onset
cold
symptom
follow
recoveri
baselin
subsequ
week
anoth
studi
strong
relationship
rhinoviru
infect
asthma
observ
children
treat
pediatr
emerg
depart
acut
wheez
rhinoviru
domin
viru
cultur
nasal
aspir
wheez
children
age
year
age
rsv
significantli
associ
wheez
wherea
combin
allergenspecif
ige
antibodi
posit
cultur
rhinoviru
particularli
strike
odd
ratio
wheez
nasal
wash
anoth
studi
children
seen
emerg
room
test
use
pcr
techniqu
rhinoviru
common
viru
associ
wheez
age
combin
allergenspecif
ige
antibodi
viral
infect
increas
risk
wheez
odd
ratio
even
strike
among
wheez
children
strong
relationship
posit
pcr
test
rhinoviru
presenc
eosinophil
ecp
nasal
secret
although
schoolag
children
experi
approxim
six
eight
cold
per
year
compar
two
three
cold
per
year
adult
recent
pcr
data
also
indic
rhinoviru
infect
associ
asthma
exacerb
adult
individu
year
respiratori
tract
pathogen
isol
children
adult
asthma
exacerb
coronaviru
identifi
caus
agent
common
cold
also
implic
attack
less
frequent
influenza
adenoviru
detect
although
mycoplasma
pneumonia
observ
communityacquir
episod
pneumonia
organ
probabl
infrequ
caus
asthma
thu
evid
sever
studi
indic
rhinoviru
major
viral
pathogen
link
attack
asthma
children
adult
inform
stimul
addit
studi
primarili
experiment
infect
adult
explor
rhinoviru
alter
lower
airway
function
import
rhinoviru
caus
common
cold
symptom
consider
inform
character
structur
rhinoviru
interact
intercellular
adhes
receptor
human
rhinovirus
repres
larg
genu
within
class
picornavirus
small
rna
virus
genu
contain
distinct
serotyp
show
antigen
divers
molecular
structur
rhinoviru
type
character
great
detail
viru
small
mm
nonenvelop
particl
within
icosahedr
protein
capsul
compos
protomer
unit
four
capsid
protein
vp
vp
vp
vp
xray
diffract
studi
shown
canyon
capsid
surfac
contain
recognit
bind
site
receptor
belong
immunoglobulin
supergroup
protein
express
lumin
surfac
epitheli
endotheli
cell
natur
ligand
lymphocyt
function
associ
antigen
wide
express
leukocyt
includ
eosinophil
upregul
induc
number
cytokin
ie
ifn
associ
recruit
leukocyt
site
inflamm
also
host
receptor
use
vast
major
goo
rhinoviru
serotyp
cell
attach
entrysn
suggest
upregul
allerg
inflamm
may
predispos
allerg
individu
higher
rate
rhinoviru
infect
lead
increas
express
inflammatori
cell
infiltr
propos
upregul
asthma
also
may
increas
probabl
rhinoviru
infect
capac
viru
provok
asthma
attack
standard
method
detect
rhinoviru
includ
viral
cultur
serolog
immunofluoresc
techniqu
mani
epidemiolog
studi
common
cold
initi
studi
experiment
rhinoviru
infect
reli
cultur
detect
recoveri
rate
rhinoviru
nasal
secret
children
experienc
natur
cold
vari
howev
rhinoviru
grow
optim
cultur
posit
result
popul
base
studi
may
underestim
preval
rhinoviru
infect
recent
pcr
method
detect
rhinoviru
rna
compar
cultur
children
common
cold
symptom
result
demonstr
detect
rate
threefold
greater
use
pcr
howev
experiment
cold
rhinoviru
recov
cultur
nasal
wash
obtain
patient
height
symptom
day
follow
inocul
ir
rais
possibl
lower
detect
rate
rhinoviru
use
cultur
individu
natur
cold
may
result
delay
obtain
sampl
abat
viral
shed
infect
progress
sever
investig
examin
rhinoviru
infect
pathogenesi
common
cold
symptom
nonallerg
individu
outlin
box
studi
explor
effect
rhinoviru
upper
lower
respiratori
tract
establish
framework
recent
studi
rhinoviru
infect
allerg
individu
time
viral
shed
relat
cold
symptom
care
examin
follow
experiment
rhinoviru
inocul
adult
volunteersir
viral
replic
nasopharynx
note
increas
day
inocul
peak
hour
cold
symptom
includ
rhiniti
pharyng
bronchiti
began
within
hour
peak
day
studi
ct
scan
adult
sinu
involv
membran
thicken
mucou
hypersecret
evid
patient
within
day
experiment
rhinoviru
inocl
indic
rhinoviru
cold
like
encompass
viral
rhinosinus
rhiniti
experiment
infect
signific
cytopath
chang
found
either
ciliat
noncili
nasal
epitheli
addit
destruct
nasal
mucosa
inferior
turbin
observ
scan
electron
microscopi
implic
find
product
cold
symptom
rhinoviru
caus
mechan
tissu
destruct
find
mark
contrast
epitheli
cell
damag
caus
adenoviru
influenza
b
viru
cell
cultur
situ
hybrid
use
local
site
determin
extent
rhinoviru
replic
experiment
infect
volunt
rhinoviru
replic
small
proport
patchi
involv
epitheli
cell
distribut
nasal
epithelium
noncili
cell
nasopharynx
follow
onset
cold
symptom
number
neutrophil
epithelium
subepitheli
cell
layer
note
increas
day
experiment
follow
influx
neutrophil
nasal
secret
lead
purul
discharg
experiment
infect
volunt
day
onset
symptom
chang
accompani
associ
chang
bacteri
pathogen
suggest
rhinoviru
may
involv
initi
neutrophil
respons
although
number
ivmdhocvt
observ
nasal
mucosa
chang
significantli
mild
lymphocyt
infiltr
note
period
even
though
local
immunopatholog
pathophysiolog
process
cold
induc
rhinoviru
fulli
understood
recent
inform
mediat
cytokin
like
contribut
knowledg
pathogenesi
event
lead
symptom
gener
level
histamin
nasal
secret
chang
significantli
acut
experiment
rhinoviru
infect
nonallerg
individu
howev
increas
concentr
kinin
act
potent
vasoact
substanc
detect
nasal
secret
adult
given
rhinoviru
experiment
symptom
sore
throat
nasal
congest
rhinorrhea
observ
healthi
volunt
administ
bradykinin
increas
level
potent
leukocyt
chemoattract
measur
nasal
secret
subject
wildtyp
rhinoviru
infect
increas
product
proinflammatori
cytokin
ie
gmcsf
ifni
tnfa
also
report
capac
rhinoviru
caus
infect
replic
lower
respiratori
tract
difficult
confirm
part
deriv
difficulti
obtain
specimen
free
contamin
studi
adult
allerg
rhiniti
infect
experiment
rhinoviru
type
viru
isol
either
fluid
cell
obtain
bronchoalveolar
lavag
bal
comparison
viru
alway
found
high
titer
nasal
wash
explan
preferenti
replic
rhinoviru
upper
airway
attribut
temperatur
sensit
cultur
may
tend
favor
replic
upper
ra
specif
reduc
temperatur
incub
rhinoviru
cultur
greatli
enhanc
efficaci
viru
isol
studi
continu
document
rhinoviru
replic
infect
lower
airway
investig
focus
inflammatori
pathway
involv
mediat
cytokin
continu
import
defin
immun
respons
stimul
viru
contrast
less
doubt
respiratori
virus
adenoviru
influenza
viru
rsv
parainfluenza
viru
infect
lower
airway
sever
studi
compar
sever
upper
respiratori
tract
symptom
lower
airway
respons
allerg
nonallerg
adult
follow
experiment
rhinoviru
inocul
studi
experiment
viral
rhiniti
bardin
colleagu
differ
atop
patient
control
observ
respect
shed
rhinoviru
symptom
score
particularli
interest
find
sever
cold
experienc
nonallerg
individu
increas
lack
preinocul
neutral
antibodi
sera
rhinoviru
serotyp
use
inocul
observ
atop
individu
develop
sever
cold
signific
increas
nasal
wash
albumin
spite
presenc
neutral
antibodi
doyl
colleagu
found
littl
evid
support
increas
suscept
atop
subject
rhinoviruslu
howev
atop
patient
experi
earlier
onset
sneez
nasal
congest
investig
examin
peripher
blood
lymphocyt
respons
experiment
infect
consist
featur
persist
tcell
activ
rhinoviru
atop
subject
week
n
f
et
n
skoner
other
group
note
experiment
rhinoviru
type
infect
induc
signific
increas
total
serum
ige
leukocyt
histamin
releas
platelet
aggreg
acut
phase
infect
adult
allerg
r
h
n
howev
acut
phase
rise
total
serum
ige
could
correl
rise
specif
ige
antibodi
allergen
test
correl
rise
serum
ige
enhanc
releas
histamin
leukocyt
stimul
antiig
antibodi
similarli
total
ige
level
atop
given
rhinoviru
infect
correl
sever
rhiniti
studi
other
thu
function
signific
rise
total
ige
infect
unclear
chang
plasma
histamin
histamin
nasal
secret
observ
nonatop
individu
rhinoviru
infect
howev
increas
histamin
secret
seen
frequent
initi
day
rhiniti
nasal
wash
allerg
adult
follow
rhinoviru
inoculatin
studi
bronchial
reactiv
increas
airway
hyperrespons
demonstr
spirometri
methacholin
challeng
observ
asthmat
subject
experiment
infect
rhinoviru
type
chang
observ
nonallerg
subject
recent
studi
ragweedallerg
patient
rhiniti
develop
increas
lower
airway
respons
inhal
histamin
ragwe
allergen
acut
infect
rhinoviru
type
interest
studi
lemansk
colleagu
patient
also
increas
likelihood
develop
late
phase
bronchoconstrictor
respons
follow
allergen
challeng
chang
remain
persist
week
experiment
infect
overal
observ
suggest
import
relationship
rhinoviru
infect
potenti
allerg
inflamm
airway
effect
bronchoprovoc
ragwe
allergen
rhinoviru
infect
examin
individu
allerg
rhiniti
calhoun
colleagu
use
segment
allergen
bronchoprovoc
method
investig
detect
increas
level
histamin
bal
sampl
immedi
hour
antigen
challeng
infect
tryptas
mast
cell
initi
detect
bal
sampl
howev
signific
increas
histamin
tryptas
late
phase
respons
suggest
basophil
rather
mast
cell
may
cell
sourc
histamin
hour
strike
observ
acut
infect
augment
recruit
eosinophil
airway
hour
allergen
challeng
moreov
effect
persist
appar
month
rhinoviru
inocul
data
indic
rhinoviru
infect
upper
respiratori
tract
significantli
augment
immedi
late
phase
cell
mediat
respons
lower
airway
allerg
individu
anoth
studi
adult
volunt
includ
six
allerg
asthmat
increas
lower
airway
respons
histamin
note
acut
phase
rhinoviru
infect
accompani
increas
submucos
lymphocyt
follow
fall
lymphocyt
number
epithelium
submucosa
detect
bronchial
biopsi
specimen
convalesc
period
increas
epitheli
eosinophil
also
note
cold
rise
eosinophil
number
persist
convalesc
asthmat
normal
subject
increas
sensit
histamin
asthmat
also
persist
convalesc
period
taken
togeth
studi
demonstr
relationship
rhinoviru
upper
respiratori
tract
infect
augment
late
phase
bronchial
respons
associ
eosinophil
recruit
lung
detail
studi
directli
link
infect
develop
eosinophil
respons
studi
defin
mechan
lead
reaction
great
interest
recent
studi
provid
evid
rhinoviru
activ
cell
monocytedepend
mechan
also
promot
eosinophil
surviv
vitrolh
link
viru
infect
allerg
eosinophil
inflamm
also
implic
mous
model
demonstr
bystand
th
cellular
respons
ovalbumin
switch
viru
peptidespecif
cell
lung
produc
lead
eosinophil
infiltr
follow
viru
peptid
challeng
epidemiolog
studi
shown
correl
season
viral
upper
respiratori
tract
infectionsparticularli
rsv
rhinovirusand
asthma
exacerb
northern
hemispher
rsv
infect
common
midwint
month
decemb
februari
month
infant
like
seen
clinic
emerg
room
hospit
acut
attack
wheez
fig
timetrend
analysi
season
pattern
respiratori
tract
infect
hospit
admiss
evalu
older
children
particularli
strong
correl
found
season
pattern
upper
respiratori
tract
infect
particularli
rhinoviru
hospit
admiss
asthma
among
children
upper
respiratori
tract
infect
admiss
asthma
also
frequent
period
school
attend
less
frequent
school
holiday
consist
peak
admiss
pediatr
emerg
room
wheez
univers
virginia
observ
annual
fall
spring
month
rhinoviru
infect
common
combin
increas
exposur
tree
grass
pollen
spring
ragwe
alternaria
higher
level
household
dust
mite
allergen
fall
fig
visit
pattern
alreadi
becom
appar
wheez
exacerb
young
children
age
diagnosi
asthma
often
consid
figur
awar
combin
season
influenc
allergen
exposur
viral
infect
help
design
treatment
plan
individu
patient
treatment
plan
includ
allergen
avoid
emphas
season
requir
daili
antiinflammatori
medic
physician
also
awar
season
influenc
like
vari
geograph
evid
infect
rhinoviru
may
augment
late
phase
respons
asthmat
individu
provid
rational
use
steroid
minim
sever
persist
airway
inflamm
decreas
relianc
patient
inhal
bronchodil
cold
children
asthma
develop
cold
peak
flow
test
use
monitor
chang
lower
airway
function
morn
peak
flow
test
check
onset
cold
symptom
durat
infect
particular
attent
focus
chang
may
occur
first
day
recent
studi
indic
inhal
steroid
may
benefit
asthmat
children
alreadi
use
inhal
steroid
daili
may
benefit
increas
dose
week
symptom
worsen
need
system
steroid
consid
patient
physician
import
question
remain
capac
viral
respiratori
tract
pathogen
augment
inflammatori
pathway
lung
asthmat
children
research
need
learn
whether
exampl
pulmonari
eosinophilia
stimul
rsv
antigen
ie
attach
g
protein
anim
human
repres
immun
respons
similar
parasit
induc
eosinophilia
whether
process
characterist
allerg
inflamm
individu
genet
predispos
develop
allerg
respiratori
symptom
asthma
absenc
cytopath
chang
respiratori
tract
epithelium
rhinoviru
cold
patchi
involv
infect
epitheli
cell
lack
direct
evid
viru
replic
infect
lower
airway
suggest
mechan
involv
enhanc
product
proinflammatori
cytokin
pathogenesi
inflamm
induc
viru
candid
cytokin
tnfa
ifni
gmcsf
current
investig
respect
cell
sourc
product
rhinoviru
infect
allerg
nonallerg
patient
addit
effort
develop
reagent
block
bind
rhinoviru
major
receptor
use
rhinoviru
infect
cell
also
repres
therapeut
approach
prevent
episod
asthma
induc
overal
understand
capac
viral
infect
precipit
wheez
attack
infant
children
improv
significantli
last
decad
need
new
inform
strategi
treat
virusinduc
asthma
exacerb
becom
import
preval
asthma
continu
increas
acknowledg
manuscript
author
grate
richard
leahi
assist
prepar
